Cargando…

Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs

Pulmonary arterial hypertension (PAH) is a malignant pulmonary vascular syndrome characterized by a progressive increase in pulmonary vascular resistance and pulmonary arterial pressure, which eventually leads to right heart failure and even death. Although the exact mechanism of PAH is not fully un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Qi, Chen, Dandan, Zhang, Xiaochun, Zhang, Feng, Zhong, Dongxiang, Lin, Dawei, Guan, Lihua, Pan, Wenzhi, Zhou, Daxin, Ge, Junbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305538/ https://www.ncbi.nlm.nih.gov/pubmed/37376028 http://dx.doi.org/10.3390/pharmaceutics15061579

Ejemplares similares

Profiling and Molecular Mechanism Analysis of Long Non-Coding RNAs and mRNAs in Pulmonary Arterial Hypertension Rat Models
por: Hou, Shiqiang, et al.
Publicado: (2021)

Initial Triple Combination Therapy for Intermediate-and High-Risk Pulmonary Arterial Hypertension: Standard of Care or Still Too Soon to Tell?
por: Jin, Qi, et al.
Publicado: (2021)

Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That’s the Question
por: Jin, Qi, et al.
Publicado: (2022)

Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Valve Stenosis in Chinese Patients
por: Hong, Nanchao, et al.
Publicado: (2022)

A prediction model for permanent pacemaker implantation after transcatheter aortic valve replacement
por: Qi, Yiming, et al.
Publicado: (2023)

Identification of recurrent variants implicated in disease in bicuspid aortic valve patients through whole-exome sequencing
por: Chen, Shasha, et al.
Publicado: (2022)

Feasibility Study of a Novel Transcatheter Tricuspid Annuloplasty System in a Porcine Model
por: Pan, Wenzhi, et al.
Publicado: (2022)

Effect of iloprost on biomarkers in patients with congenital heart disease‐pulmonary arterial hypertension
por: Li, Xiao‐ye, et al.
Publicado: (2017)

A Novel Puncturable Atrial Septal Defect Occluder: The Results of Preclinical Experiment and First-in-Human Study
por: Zhang, Xiaochun, et al.
Publicado: (2022)

A study on correlation between preprocedural CT indexes and procedural success rate of transfemoral transcatheter aortic valve replacement with different self-expanding valves (VitaFlow or VenusA-Valve) in patients with pure native aortic regurgitation
por: Chen, Shasha, et al.
Publicado: (2022)

Preliminary Implantation of a Novel TAVR Device With Polymeric Leaflets for Symptomatic Calcific Aortic Disease
por: Ge, Junbo, et al.
Publicado: (2023)

Pericardial Effusion During the Perioperative Period for Left Atrial Appendage Closure
por: Yang, Lifan, et al.
Publicado: (2021)

Transcatheter Aortic Valve Replacement for Bicuspid vs. Tricuspid Aortic Stenosis among Patients at Low Surgical Risk in China: From the Multicenter National NTCVR Database
por: Hong, Nanchao, et al.
Publicado: (2023)

Impact of Thrombocytopenia in Patients With Atrial Fibrillation Undergoing Left Atrial Appendage Occlusion: A Propensity-Matched Comparison of 190 Consecutive Watchman Implantations
por: Zhang, Xiaochun, et al.
Publicado: (2021)

Real-Time Monitoring and Step-by-Step Guidance for Transapical Mitral Valve Edge-to-Edge Repair Using Transesophageal Echocardiography
por: Ge, Zhenyi, et al.
Publicado: (2021)

Impact of Leaflet Tethering on Residual Regurgitation in Patients With Degenerative Mitral Disease After Interventional Edge-to-Edge Repair
por: Ge, Zhenyi, et al.
Publicado: (2021)

Current status of pulmonary arterial hypertension in Korea
por: Jang, Albert Youngwoo, et al.
Publicado: (2019)

Clinical outcomes of bivalirudin versus heparin in atrial fibrillation patients undergoing percutaneous left atrial appendage occlusion
por: Zhang, Xiaochun, et al.
Publicado: (2021)

Increased serum PCSK9 in patients with idiopathic pulmonary arterial hypertension: insights from inflammatory cytokines
por: Zhong, Dong-Xiang, et al.
Publicado: (2021)

The Impact of Dabigatran and Rivaroxaban on Variation of Platelet Activation Biomarkers and DRT Following Percutaneous Left Atrial Appendage Closure
por: Li, Xiaoye, et al.
Publicado: (2021)

Aortic valve morphology and paravalvular leak regression after a self-expandable transcatheter aortic valve replacement
por: Jin, Qinchun, et al.
Publicado: (2023)

Real-Time Monitoring and Step-by-Step Guidance for Transcatheter Tricuspid Annuloplasty Using Transesophageal Echocardiography
por: Liu, Yu, et al.
Publicado: (2022)

Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
por: Coons, James C, et al.
Publicado: (2023)

Mitochondrial dysfunction in pulmonary arterial hypertension
por: Zhang, Weiwei, et al.
Publicado: (2022)

Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials
por: Wang, An, et al.
Publicado: (2023)

Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation
por: Li, Xiaoye, et al.
Publicado: (2021)

Pulmonary arterial hypertension: tailoring treatment to risk in the current era
por: Gaine, Sean, et al.
Publicado: (2017)

Current Trends and Movements in Managing Pulmonary Arterial Hypertension in Korea
por: Seung, Jaeho, et al.
Publicado: (2023)

Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2019)

Gut microbiome alterations in pulmonary hypertension in highlanders and lowlanders
por: Dong, Wenxue, et al.
Publicado: (2023)

Role of macrophages in pulmonary arterial hypertension
por: Zhang, Meng-Qi, et al.
Publicado: (2023)

Management of Pulmonary Arterial Hypertension
por: Mayeux, Jennalyn D., et al.
Publicado: (2020)

Current practices in the use of sildenafil for pulmonary arterial hypertension in Brazilian hospitals
por: de Souza, Ana HA, et al.
Publicado: (2009)

Micro-RNA Analysis in Pulmonary Arterial Hypertension: Current Knowledge and Challenges
por: Santos-Ferreira, Cátia A., et al.
Publicado: (2020)

Current Understanding of the Right Ventricle Structure and Function in Pulmonary Arterial Hypertension
por: Sharifi Kia, Danial, et al.
Publicado: (2021)

Comparative Transcriptional Analysis of Pulmonary Arterial Hypertension Associated With Three Different Diseases
por: Wang, Wei, et al.
Publicado: (2021)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pulmonary Arterial Hypertension
por: Michelakis, Evangelos D., et al.
Publicado: (2007)

New Drugs and Therapies in Pulmonary Arterial Hypertension
por: Shah, Aangi J., et al.
Publicado: (2023)

Clinical outcomes of bicuspid versus tricuspid aortic valve stenosis after transcatheter aortic valve replacement with self-expandable valves
por: Jin, Qinchun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g81318j5jq3jvpq9ms7tfl3574